美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Enliven Treateutics

22.48

+0.02500.11%

成交量：5.15萬

成交額：115.83萬

市值：12.92億

市盈率：-11.63

高：22.87

開：22.41

低：21.80

收：22.45

資料載入中...

總覽公司新聞公告

Enliven Therapeutics, Inc.6月26日成交額為993.95萬美元

Enliven Therapeutics(ELVN.US)獲高盛首次覆蓋，給予買入評級, 目標價37.00美元。

Enliven Therapeutics, Inc.2025財年第一財季實現淨利潤-28.54百萬美元，同比減少25.51%

Enliven Therapeutics, Inc.盤中異動臨近收盤股價大跌5.22%報16.89美元

Enliven Therapeutics, Inc.盤中異動早盤大幅下跌9.25%報18.05美元

Enliven Therapeutics公司公佈截至3月31日的季度業績 - 收益摘要

Enliven Therapeutics, Inc.盤中異動早盤快速拉昇5.02%

Enliven Therapeutics, Inc.盤中異動早盤急速上漲5.07%

Enliven Therapeutics, Inc.盤中異動早盤股價大漲5.86%報19.34美元

Enliven Therapeutics, Inc.盤中異動股價大漲5.07%報19.90美元

Enliven Therapeutics, Inc.盤中異動快速拉昇5.02%報19.13美元

Enliven Therapeutics, Inc.盤中異動股價大漲5.86%報17.17美元

Enliven Therapeutics, Inc.盤中異動早盤股價大跌5.99%報15.53美元

Enliven Therapeutics, Inc.盤中異動早盤股價大跌5.50%報14.95美元

Enliven Therapeutics, Inc.盤中異動快速下挫5.08%報17.74美元

Enliven Therapeutics, Inc.盤中異動早盤股價大跌5.11%

Enliven Therapeutics, Inc.2024財年實現淨利潤-89.02百萬美元，同比減少24.36%

Enliven Therapeutics 2024年第四季度GAAP每股收益$(0.46)優於預期$(0.52)

Enliven Therapeutics, Inc.盤中異動急速跳水5.10%報19.93美元

Enliven Therapeutics, Inc.盤中異動股價大漲5.07%報20.93美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ELVN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","market":"US","secType":"STK","nameCN":"Enliven Treateutics","latestPrice":22.475,"timestamp":1752509669875,"preClose":22.45,"halted":0,"volume":51454,"delay":0,"floatShares":34999600,"shares":57464000,"eps":-1.932389,"marketStatus":"交易中","change":0.025,"latestTime":"07-14 12:14:56 EDT","open":22.41,"high":22.87,"low":21.8,"amount":1158289.792634,"amplitude":0.047661,"askPrice":22.56,"askSize":387,"bidPrice":22.39,"bidSize":147,"shortable":3,"etf":0,"ttmEps":-1.932389,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1752523200000},"marketStatusCode":2,"adr":0,"listingDate":1583985600000,"exchange":"NASDAQ","adjPreClose":22.45,"preHourTrading":{"tag":"盘前","latestPrice":21.75,"preClose":22.45,"latestTime":"08:00 EDT","volume":10,"amount":217.5,"timestamp":1752494401769},"postHourTrading":{"tag":"盘后","latestPrice":22.45,"preClose":22.45,"latestTime":"16:10 EDT","volume":15047,"amount":337805.15,"timestamp":1752264655033},"volumeRatio":0.277552,"impliedVol":0.7463,"impliedVolPercentile":0.628},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","floatShares":34999600,"roa":"-21.36%","roe":"-31.30%","lyrEps":-1.891209,"volumeRatio":0.277552,"shares":57464000,"dividePrice":0,"high":22.87,"amplitude":0.047661,"preClose":22.45,"low":21.8,"week52Low":13.3,"pbRate":"4.48","week52High":30.03,"institutionHeld":0,"latestPrice":22.475,"committee":-0.449438,"eps":-1.932389,"divideRate":0,"volume":51454,"delay":0,"ttmEps":-1.932389,"open":22.41,"prevYearClose":22.5,"prevWeekClose":22.45,"prevMonthClose":20.06,"prevQuarterClose":20.06,"fiveDayClose":19.59,"twentyDayClose":19.66,"sixtyDayClose":17.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELVN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546761341","title":"Enliven Therapeutics, Inc.6月26日成交額為993.95萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546761341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546761341?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 09:57","pubTimestamp":1750989435,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日，Enliven Therapeutics, Inc.成交额为993.95万美元，成交额较昨日减少3.17%，当日成交量为46.65万股。Enliven Therapeutics, Inc.于2025年6月26日涨0.09%，报21.52美元，该股过去5个交易日跌0.23%，年初至今跌4.36%，过去60日涨9.35%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-26|993.95万|-3.17%|46.65万|#|2025-06-25|1026.48万|-24.15%|48.51万|#|2025-06-24|1353.35万|5.20%|64.53万|#|2025-06-23|1286.40万|15.44%|62.46万|#|2025-06-20|1114.38万|20.24%|51.85万|Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627095718a4c012b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627095718a4c012b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELVN","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2543038986","title":"Enliven Therapeutics(ELVN.US)獲高盛首次覆蓋，給予買入評級, 目標價37.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543038986","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543038986?lang=zh_tw&edition=fundamental","pubTime":"2025-06-16 21:45","pubTimestamp":1750081519,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics(ELVN.US)获高盛首次覆盖，给予买入评级, 目标价37.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/16214551098387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ELVN"],"gpt_icon":0},{"id":"2537923449","title":"Enliven Therapeutics, Inc.2025財年第一財季實現淨利潤-28.54百萬美元，同比減少25.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923449","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537923449?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 00:00","pubTimestamp":1747929641,"startTime":"0","endTime":"0","summary":"5月23日，Enliven Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-28.54百万美元，同比减少25.51%；其中营业收入为0.00美元，每股基本收益为-0.57美元。机构评级：截至2025年5月23日，当前有8家机构对Enliven Therapeutics, Inc.目标价做出预测，其中目标均价为37.25美元，其中最低目标价为27.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000216a4887706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000216a4887706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELVN"],"gpt_icon":0},{"id":"2536574347","title":"Enliven Therapeutics, Inc.盤中異動 臨近收盤股價大跌5.22%報16.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536574347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536574347?lang=zh_tw&edition=fundamental","pubTime":"2025-05-17 03:39","pubTimestamp":1747424387,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日03时39分，Enliven Therapeutics, Inc.股票出现波动，股价大幅下挫5.22%。截至发稿，该股报16.89美元/股，成交量32.1183万股，换手率0.65%，振幅8.61%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517033947a6e2036f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517033947a6e2036f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","LENZ","BK4139","ELVN"],"gpt_icon":0},{"id":"2535824382","title":"Enliven Therapeutics, Inc.盤中異動 早盤大幅下跌9.25%報18.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535824382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535824382?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 21:31","pubTimestamp":1747315919,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时31分，Enliven Therapeutics, Inc.股票出现异动，股价急速跳水9.25%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Nucana Plc、Abpro Holdings, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为6169.74%、1829.97%、270.48%，振幅较大的相关个股有Nucana Plc、Pasithea Therapeutics Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为23.99%、19.83%、14.15%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213159975abedd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213159975abedd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BK4139","ELVN"],"gpt_icon":0},{"id":"2535100012","title":"Enliven Therapeutics公司公佈截至3月31日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2535100012","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535100012?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 04:35","pubTimestamp":1747254945,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics公司公布截至3月31日的季度业绩 - 收益摘要Enliven Therapeutics Inc ELVN.OQ报告，截至3月31日的季度调整后每股亏损57美分，低于去年同期的每股收益-54美分。七位分析师对该季度的平均预期是每股亏损 50 美分。Enliven Therapeutics Inc 公布的季度每股收益为亏损 57 美分。该公司当季亏损2854万美元。Enliven Therapeutics Inc本季度股价上涨了1.8%，今年迄今为止亏损了11.0%。华尔街对 Enliven Therapeutics Inc 的 12 个月目标价中位数为 39.00 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4T3RM1UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"gpt_icon":0},{"id":"2535204234","title":"Enliven Therapeutics, Inc.盤中異動 早盤快速拉昇5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535204234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535204234?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 21:53","pubTimestamp":1747058019,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时53分，Enliven Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.75%。其相关个股中，Cytomx Therapeutics, Inc.、艾吉纳斯、艾切托涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为410.21%、83.09%、60.95%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、艾吉纳斯，振幅分别为49.55%、35.18%、32.98%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512215340a6dc56a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512215340a6dc56a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BK4139","ELVN"],"gpt_icon":0},{"id":"2534436292","title":"Enliven Therapeutics, Inc.盤中異動 早盤急速上漲5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436292?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:51","pubTimestamp":1746798679,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时51分，Enliven Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为549.15%、128.72%、14.34%，振幅较大的相关个股有Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. 、Carisma Therapeutics, Inc.，振幅分别为39.52%、22.15%、20.76%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215119aa2c8915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215119aa2c8915&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELVN","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2533391161","title":"Enliven Therapeutics, Inc.盤中異動 早盤股價大漲5.86%報19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533391161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533391161?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 21:32","pubTimestamp":1746711166,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时32分，Enliven Therapeutics, Inc.股票出现波动，股价大幅拉升5.86%。截至发稿，该股报19.34美元/股，成交量4631股，换手率0.01%，振幅2.85%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213246a476cf7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213246a476cf7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ELVN"],"gpt_icon":0},{"id":"2532884509","title":"Enliven Therapeutics, Inc.盤中異動 股價大漲5.07%報19.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532884509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532884509?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 02:42","pubTimestamp":1746124956,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日02时42分，Enliven Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。截至发稿，该股报19.90美元/股，成交量11.0076万股，换手率0.22%，振幅5.86%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502024236aa2c8103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502024236aa2c8103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ELVN"],"gpt_icon":0},{"id":"2531145250","title":"Enliven Therapeutics, Inc.盤中異動 快速拉昇5.02%報19.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531145250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531145250?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 03:52","pubTimestamp":1745869935,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日03时52分，Enliven Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Aardvark Therapeutics, Inc.、Cg Oncology, Inc.、Regulus Therapeutics Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Onconetix, Inc.较为活跃，换手率分别为2644.74%、522.54%、135.37%，振幅较大的相关个股有Relmada Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Cyclacel Pharmaceuticals, Inc.，振幅分别为68.35%、67.52%、60.43%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429035215aa2c7d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429035215aa2c7d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ELVN"],"gpt_icon":0},{"id":"2529586964","title":"Enliven Therapeutics, Inc.盤中異動 股價大漲5.86%報17.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529586964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529586964?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:30","pubTimestamp":1745328636,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时30分，Enliven Therapeutics, Inc.股票出现异动，股价急速上涨5.86%。截至发稿，该股报17.17美元/股，成交量843股，换手率0.00%，振幅0.00%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221303794de31ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221303794de31ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELVN","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2526553560","title":"Enliven Therapeutics, Inc.盤中異動 早盤股價大跌5.99%報15.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526553560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526553560?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:32","pubTimestamp":1744291958,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时32分，Enliven Therapeutics, Inc.股票出现波动，股价快速下跌5.99%。截至发稿，该股报15.53美元/股，成交量1.0914万股，换手率0.02%，振幅0.00%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213238a4550151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213238a4550151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELVN","LENZ","BK4007"],"gpt_icon":0},{"id":"2526969813","title":"Enliven Therapeutics, Inc.盤中異動 早盤股價大跌5.50%報14.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526969813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526969813?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 22:51","pubTimestamp":1744210315,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日22时51分，Enliven Therapeutics, Inc.股票出现异动，股价急速下挫5.50%。截至发稿，该股报14.95美元/股，成交量5.3078万股，换手率0.11%，振幅5.21%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.09%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040922515594d0e96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040922515594d0e96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ELVN","BK4139"],"gpt_icon":0},{"id":"2525023100","title":"Enliven Therapeutics, Inc.盤中異動 快速下挫5.08%報17.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525023100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525023100?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:36","pubTimestamp":1744032993,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时36分，Enliven Therapeutics, Inc.股票出现异动，股价大幅下挫5.08%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.39%。其相关个股中，Telix Pharmaceutic、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Transcode Therapeutics, Inc.、Tharimmune, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为54.90%、21.68%、21.15%，振幅较大的相关个股有Clearside Biomedical, Inc.、Sutro Biopharma, Inc.、Orchestra Biomed Holdings, Inc.，振幅分别为109.12%、109.00%、107.54%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213633aa2c5f08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213633aa2c5f08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ELVN","BK4139"],"gpt_icon":0},{"id":"2524250278","title":"Enliven Therapeutics, Inc.盤中異動 早盤股價大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524250278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524250278?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 21:41","pubTimestamp":1743687716,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时41分，Enliven Therapeutics, Inc.股票出现波动，股价大幅下挫5.11%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Protagenic Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为2377.37%、1275.66%、331.82%，振幅较大的相关个股有Protagenic Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.，振幅分别为52.42%、51.45%、31.94%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403214156a44cbe6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403214156a44cbe6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ELVN","BK4139"],"gpt_icon":0},{"id":"2520982927","title":"Enliven Therapeutics, Inc.2024財年實現淨利潤-89.02百萬美元，同比減少24.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520982927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520982927?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 02:00","pubTimestamp":1742320827,"startTime":"0","endTime":"0","summary":"3月19日，Enliven Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-89.02百万美元，同比减少24.36%；其中营业收入为0.00美元，每股基本收益为-1.89美元。从资产负债表来看，Enliven Therapeutics, Inc.总负债15.92百万美元，其中短期债务0.00美元，资产负债比为0.21，流动比率为0.20。机构评级：截至2025年3月19日，当前有7家机构对Enliven Therapeutics, Inc.目标价做出预测，其中目标均价为37.71美元，其中最低目标价为33.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319020038a69ae360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319020038a69ae360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELVN","LENZ"],"gpt_icon":0},{"id":"1106598113","title":"Enliven Therapeutics 2024年第四季度GAAP每股收益$(0.46)優於預期$(0.52)","url":"https://stock-news.laohu8.com/highlight/detail?id=1106598113","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106598113?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 04:24","pubTimestamp":1741897479,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics  报告季度每股亏损$，优于分析师共识预期的每股亏损$，超出11.54%。这比去年同期每股亏损$增加了2.13%。以上内容来自Benzinga Earnings专栏，原文如下：Enliven $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.54 percent. This is a 2.13 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","LENZ"],"gpt_icon":0},{"id":"2518031273","title":"Enliven Therapeutics, Inc.盤中異動 急速跳水5.10%報19.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518031273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518031273?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 22:24","pubTimestamp":1741616661,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时24分，Enliven Therapeutics, Inc.股票出现异动，股价急速下挫5.10%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3410.94%、721.77%、415.50%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的精准肿瘤学公司，专注于发现和开发潜在的一流精准肿瘤疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222421a26a38fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222421a26a38fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ELVN","BK4007"],"gpt_icon":0},{"id":"2517929888","title":"Enliven Therapeutics, Inc.盤中異動 股價大漲5.07%報20.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517929888?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 04:33","pubTimestamp":1741206800,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时33分，Enliven Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.91%。其相关个股中，Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为975.81%、319.18%、318.25%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为82.59%、54.27%、51.93%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的精准肿瘤学公司，专注于发现和开发潜在的一流精准肿瘤疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043321a2612b77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043321a2612b77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELVN","LENZ","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ELVN","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2025-03-13","symbol":"ELVN","fiscalQuarterEnding":"2024/12","expectedEps":-0.53,"name":null,"time":"盤後","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-11-13","symbol":"ELVN","fiscalQuarterEnding":"2024/09","expectedEps":-0.52,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-08-13","symbol":"ELVN","fiscalQuarterEnding":"2024/06","expectedEps":-0.58,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2024-05-14","symbol":"ELVN","fiscalQuarterEnding":"2024/03","expectedEps":-0.58,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1750132800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELVN","date":"2025-07-11","current":-14.170598,"percent":0.294737,"low":-26.682642,"twenty":-16.684047,"median":-12.73506,"eighty":-10.29197,"high":-6.665619,"avg":-13.65469,"sd":4.310066,"marketCap":1343797781},"quantilePoints":[{"date":"2023-02-24","current":-26.682642,"twenty":-26.682642,"median":-26.682642,"eighty":-26.682642,"marketCap":974023148},{"date":"2023-03-03","current":-24.8289,"twenty":-26.345598,"median":-24.559265,"eighty":-24.199752,"marketCap":906354172},{"date":"2023-03-10","current":-23.694186,"twenty":-25.199648,"median":-24.28963,"eighty":-23.806534,"marketCap":864932556},{"date":"2023-03-17","current":-24.997422,"twenty":-25.053596,"median":-24.508708,"eighty":-23.817768,"marketCap":912505897},{"date":"2023-03-24","current":-25.045524,"twenty":-25.045524,"median":-24.501056,"eighty":-23.817768,"marketCap":943264523},{"date":"2023-03-31","current":-23.847695,"twenty":-25.154418,"median":-24.513309,"eighty":-23.847695,"marketCap":898151871},{"date":"2023-04-06","current":-25.11086,"twenty":-25.119572,"median":-24.513309,"eighty":-23.847695,"marketCap":945725213},{"date":"2023-04-14","current":-20.962015,"twenty":-25.076502,"median":-24.390743,"eighty":-23.811629,"marketCap":789471394},{"date":"2023-04-21","current":-21.332253,"twenty":-25.048753,"median":-24.119928,"eighty":-22.848051,"marketCap":803415304},{"date":"2023-04-28","current":-20.635334,"twenty":-25.016663,"median":-23.926845,"eighty":-21.458569,"marketCap":777167943},{"date":"2023-05-05","current":-20.341321,"twenty":-24.896309,"median":-23.847695,"eighty":-21.260383,"marketCap":766094838},{"date":"2023-05-12","current":-20.851059,"twenty":-24.795534,"median":-23.81078,"eighty":-20.994683,"marketCap":785292584},{"date":"2023-05-19","current":-21.89907,"twenty":-24.705543,"median":-23.593073,"eighty":-21.113722,"marketCap":824762787},{"date":"2023-05-26","current":-21.462399,"twenty":-24.613192,"median":-22.720646,"eighty":-21.211975,"marketCap":808316869},{"date":"2023-06-02","current":-18.734285,"twenty":-24.559265,"median":-21.980633,"eighty":-20.954392,"marketCap":819006716},{"date":"2023-06-09","current":-21.377022,"twenty":-24.515759,"median":-21.83357,"eighty":-20.954392,"marketCap":934539290},{"date":"2023-06-16","current":-18.254642,"twenty":-24.497376,"median":-21.673899,"eighty":-20.758384,"marketCap":798038170},{"date":"2023-06-23","current":-20.812737,"twenty":-24.451411,"median":-21.642525,"eighty":-20.734427,"marketCap":909870413},{"date":"2023-06-30","current":-18.32988,"twenty":-24.28963,"median":-21.616844,"eighty":-20.341321,"marketCap":801327354},{"date":"2023-07-07","current":-17.361189,"twenty":-24.217728,"median":-21.517191,"eighty":-20.09872,"marketCap":758979115},{"date":"2023-07-14","current":-17.135475,"twenty":-24.135893,"median":-21.462399,"eighty":-19.332427,"marketCap":749111564},{"date":"2023-07-21","current":-17.972499,"twenty":-24.119928,"median":-21.435107,"eighty":-18.517975,"marketCap":785703732},{"date":"2023-07-28","current":-16.984999,"twenty":-23.971833,"median":-21.377022,"eighty":-18.220785,"marketCap":742533197},{"date":"2023-08-04","current":-16.881547,"twenty":-23.922067,"median":-21.256028,"eighty":-17.820142,"marketCap":738010570},{"date":"2023-08-11","current":-16.491696,"twenty":-23.861932,"median":-21.016461,"eighty":-17.568094,"marketCap":720967464},{"date":"2023-08-18","current":-12.980214,"twenty":-23.847695,"median":-20.922018,"eighty":-17.248332,"marketCap":669117064},{"date":"2023-08-25","current":-13.578933,"twenty":-23.823753,"median":-20.812737,"eighty":-17.129832,"marketCap":699980398},{"date":"2023-09-01","current":-12.469308,"twenty":-23.815574,"median":-20.736061,"eighty":-17.000046,"marketCap":642780353},{"date":"2023-09-08","current":-12.908368,"twenty":-23.809931,"median":-20.564155,"eighty":-16.862737,"marketCap":665413464},{"date":"2023-09-15","current":-13.123907,"twenty":-23.739125,"median":-20.333094,"eighty":-16.776213,"marketCap":676524264},{"date":"2023-09-22","current":-10.154264,"twenty":-23.633518,"median":-19.996164,"eighty":-15.495828,"marketCap":523442131},{"date":"2023-09-29","current":-10.968521,"twenty":-23.474031,"median":-19.373808,"eighty":-13.527842,"marketCap":565416265},{"date":"2023-10-06","current":-11.511359,"twenty":-23.372472,"median":-19.044642,"eighty":-13.224491,"marketCap":593399020},{"date":"2023-10-13","current":-9.994605,"twenty":-22.593241,"median":-18.52738,"eighty":-13.107941,"marketCap":515211909},{"date":"2023-10-20","current":-10.130315,"twenty":-22.058041,"median":-18.391011,"eighty":-12.999373,"marketCap":522207598},{"date":"2023-10-27","current":-9.555545,"twenty":-22.040989,"median":-18.292261,"eighty":-12.964248,"marketCap":492578798},{"date":"2023-11-03","current":-9.731169,"twenty":-21.920278,"median":-17.972499,"eighty":-12.485274,"marketCap":501632043},{"date":"2023-11-10","current":-7.695346,"twenty":-21.89907,"median":-17.817321,"eighty":-12.245786,"marketCap":475295332},{"date":"2023-11-17","current":-6.952736,"twenty":-21.83357,"median":-17.803213,"eighty":-11.215991,"marketCap":429428758},{"date":"2023-11-24","current":-7.786797,"twenty":-21.720035,"median":-17.492856,"eighty":-10.958941,"marketCap":480943724},{"date":"2023-12-01","current":-7.513225,"twenty":-21.68071,"median":-17.309463,"eighty":-10.760965,"marketCap":464046815},{"date":"2023-12-08","current":-7.506552,"twenty":-21.671453,"median":-17.210713,"eighty":-10.505512,"marketCap":463634696},{"date":"2023-12-15","current":-7.893557,"twenty":-21.652352,"median":-17.121368,"eighty":-10.333081,"marketCap":487537640},{"date":"2023-12-22","current":-8.620858,"twenty":-21.63925,"median":-17.013213,"eighty":-10.031327,"marketCap":532458691},{"date":"2023-12-29","current":-9.721819,"twenty":-21.630859,"median":-16.994403,"eighty":-9.985025,"marketCap":600458446},{"date":"2024-01-05","current":-9.735164,"twenty":-21.621546,"median":-16.919166,"eighty":-9.908649,"marketCap":601282686},{"date":"2024-01-12","current":-7.653347,"twenty":-21.612141,"median":-16.825118,"eighty":-9.735164,"marketCap":472701330},{"date":"2024-01-19","current":-8.547461,"twenty":-21.544748,"median":-16.787499,"eighty":-9.657763,"marketCap":527925374},{"date":"2024-01-26","current":-10.90285,"twenty":-21.510766,"median":-16.702856,"eighty":-9.657763,"marketCap":673403638},{"date":"2024-02-02","current":-10.972911,"twenty":-21.471637,"median":-15.246862,"eighty":-9.711143,"marketCap":677730895},{"date":"2024-02-09","current":-10.282309,"twenty":-21.462504,"median":-13.618847,"eighty":-9.729299,"marketCap":635076503},{"date":"2024-02-16","current":-11.543409,"twenty":-21.454109,"median":-13.399317,"eighty":-9.734365,"marketCap":712967132},{"date":"2024-02-23","current":-10.609261,"twenty":-21.445153,"median":-13.291548,"eighty":-9.761506,"marketCap":655270370},{"date":"2024-03-01","current":-10.655968,"twenty":-21.434015,"median":-13.147855,"eighty":-9.803015,"marketCap":658155208},{"date":"2024-03-08","current":-10.275636,"twenty":-21.409359,"median":-13.10395,"eighty":-9.82474,"marketCap":634664384},{"date":"2024-03-15","current":-6.665619,"twenty":-21.384546,"median":-13.044078,"eighty":-9.733566,"marketCap":477151673},{"date":"2024-03-22","current":-10.431636,"twenty":-21.350161,"median":-12.972231,"eighty":-9.727429,"marketCap":746738233},{"date":"2024-03-28","current":-10.760874,"twenty":-21.310474,"median":-12.880428,"eighty":-9.732767,"marketCap":770306384},{"date":"2024-04-05","current":-12.135517,"twenty":-21.260383,"median":-12.485274,"eighty":-9.752725,"marketCap":868708833},{"date":"2024-04-12","current":-15.541291,"twenty":-21.211975,"median":-12.53879,"eighty":-9.795033,"marketCap":1112507764},{"date":"2024-04-19","current":-11.553574,"twenty":-21.113722,"median":-12.520461,"eighty":-9.82282,"marketCap":827051011},{"date":"2024-04-26","current":-10.971645,"twenty":-20.994683,"median":-12.453342,"eighty":-9.833917,"marketCap":785394226},{"date":"2024-05-03","current":-13.724364,"twenty":-20.956933,"median":-12.42141,"eighty":-9.861485,"marketCap":982444863},{"date":"2024-05-10","current":-15.627075,"twenty":-20.927476,"median":-12.477291,"eighty":-9.897956,"marketCap":1118648510},{"date":"2024-05-17","current":-14.069999,"twenty":-20.877259,"median":-12.55712,"eighty":-9.908649,"marketCap":1119943779},{"date":"2024-05-24","current":-13.579529,"twenty":-20.83573,"median":-12.880428,"eighty":-9.913987,"marketCap":1080903320},{"date":"2024-05-31","current":-13.31952,"twenty":-20.807747,"median":-12.919935,"eighty":-9.925997,"marketCap":1060207172},{"date":"2024-06-07","current":-11.936748,"twenty":-20.777985,"median":-12.852488,"eighty":-9.949337,"marketCap":950141299},{"date":"2024-06-14","current":-13.012238,"twenty":-20.738783,"median":-12.908368,"eighty":-9.978639,"marketCap":1035748089},{"date":"2024-06-21","current":-12.433128,"twenty":-20.734427,"median":-12.823141,"eighty":-9.991412,"marketCap":989652125},{"date":"2024-06-28","current":-13.857265,"twenty":-20.713737,"median":-12.852488,"eighty":-9.999395,"marketCap":1103010568},{"date":"2024-07-05","current":-12.734501,"twenty":-20.635334,"median":-12.852488,"eighty":-10.018554,"marketCap":1013640841},{"date":"2024-07-12","current":-14.217731,"twenty":-20.492975,"median":-12.947875,"eighty":-10.03452,"marketCap":1131702953},{"date":"2024-07-15","current":-14.619562,"twenty":-20.462644,"median":-12.964248,"eighty":-10.034701,"marketCap":1163687908},{"date":"2024-08-02","current":-14.595925,"twenty":-20.432313,"median":-12.972231,"eighty":-10.034882,"marketCap":1161806440},{"date":"2024-08-09","current":-12.834959,"twenty":-20.33803,"median":-12.964248,"eighty":-10.054109,"marketCap":1021637080},{"date":"2024-08-16","current":-13.556309,"twenty":-20.306761,"median":-12.945278,"eighty":-10.088634,"marketCap":1122828410},{"date":"2024-08-23","current":-13.060138,"twenty":-20.227193,"median":-12.964248,"eighty":-10.111156,"marketCap":1081732040},{"date":"2024-08-30","current":-12.672326,"twenty":-20.030349,"median":-12.961651,"eighty":-10.130701,"marketCap":1049610739},{"date":"2024-09-06","current":-12.495529,"twenty":-19.786892,"median":-12.919935,"eighty":-10.135876,"marketCap":1034967205},{"date":"2024-09-13","current":-12.73506,"twenty":-19.581572,"median":-12.931502,"eighty":-10.154517,"marketCap":1054806832},{"date":"2024-09-20","current":-13.157091,"twenty":-19.368165,"median":-12.8873,"eighty":-10.156457,"marketCap":1089762365},{"date":"2024-09-27","current":-13.755918,"twenty":-19.332427,"median":-12.959054,"eighty":-10.16247,"marketCap":1139361432},{"date":"2024-10-04","current":-14.548651,"twenty":-19.185713,"median":-12.995005,"eighty":-10.191351,"marketCap":1205021150},{"date":"2024-10-11","current":-15.381306,"twenty":-18.794475,"median":-13.012238,"eighty":-10.271051,"marketCap":1273987472},{"date":"2024-10-18","current":-15.980134,"twenty":-18.692904,"median":-13.06278,"eighty":-10.276971,"marketCap":1323586540},{"date":"2024-10-25","current":-16.527633,"twenty":-18.517975,"median":-13.077247,"eighty":-10.282309,"marketCap":1368934258},{"date":"2024-10-31","current":-16.191149,"twenty":-18.480356,"median":-13.117169,"eighty":-10.282309,"marketCap":1341064306},{"date":"2024-11-08","current":-16.539039,"twenty":-18.452142,"median":-13.127899,"eighty":-10.308998,"marketCap":1369879003},{"date":"2024-11-15","current":-14.288385,"twenty":-18.32988,"median":-13.147855,"eighty":-10.377785,"marketCap":1217570416},{"date":"2024-11-22","current":-14.569336,"twenty":-18.254642,"median":-13.191309,"eighty":-10.377785,"marketCap":1241511408},{"date":"2024-11-29","current":-13.978765,"twenty":-18.119213,"median":-13.257473,"eighty":-10.420866,"marketCap":1191186467},{"date":"2024-12-06","current":-13.330857,"twenty":-17.99507,"median":-13.275582,"eighty":-10.465191,"marketCap":1135975609},{"date":"2024-12-13","current":-13.187514,"twenty":-17.927356,"median":-13.313517,"eighty":-10.47358,"marketCap":1123760818},{"date":"2024-12-20","current":-13.112976,"twenty":-17.840832,"median":-13.307514,"eighty":-10.475365,"marketCap":1117409126},{"date":"2024-12-27","current":-13.021237,"twenty":-17.81638,"median":-13.27352,"eighty":-10.487821,"marketCap":1109591659},{"date":"2025-01-03","current":-13.703547,"twenty":-17.808856,"median":-13.27352,"eighty":-10.502895,"marketCap":1167734067},{"date":"2025-01-10","current":-13.84689,"twenty":-17.803213,"median":-13.275582,"eighty":-10.521478,"marketCap":1179948858},{"date":"2025-01-17","current":-12.60841,"twenty":-17.759951,"median":-13.27352,"eighty":-10.564579,"marketCap":1074413060},{"date":"2025-01-24","current":-12.637079,"twenty":-17.586904,"median":-13.268745,"eighty":-10.609261,"marketCap":1076856018},{"date":"2025-01-31","current":-12.195584,"twenty":-17.492856,"median":-13.225528,"eighty":-10.642623,"marketCap":1039234460},{"date":"2025-02-07","current":-12.883628,"twenty":-17.445832,"median":-13.157091,"eighty":-10.649204,"marketCap":1097865460},{"date":"2025-02-14","current":-12.327459,"twenty":-17.361189,"median":-13.147855,"eighty":-10.655968,"marketCap":1050472069},{"date":"2025-02-21","current":-12.310258,"twenty":-17.278427,"median":-13.123907,"eighty":-10.661306,"marketCap":1049006294},{"date":"2025-02-28","current":-11.553409,"twenty":-17.220118,"median":-13.115073,"eighty":-10.671914,"marketCap":984512194},{"date":"2025-03-07","current":-12.304524,"twenty":-17.210713,"median":-13.077247,"eighty":-10.692528,"marketCap":1048517702},{"date":"2025-03-14","current":-11.168896,"twenty":-17.203189,"median":-13.06278,"eighty":-10.70156,"marketCap":994299783},{"date":"2025-03-21","current":-11.515688,"twenty":-17.148642,"median":-13.044078,"eighty":-10.73075,"marketCap":1025172571},{"date":"2025-03-28","current":-11.840461,"twenty":-17.112904,"median":-13.012192,"eighty":-10.756253,"marketCap":1054085181},{"date":"2025-04-04","current":-11.025775,"twenty":-17.062118,"median":-12.992568,"eighty":-10.756253,"marketCap":981558632},{"date":"2025-04-11","current":-8.207404,"twenty":-17.020737,"median":-12.961651,"eighty":-10.671914,"marketCap":730655976},{"date":"2025-04-17","current":-8.845942,"twenty":-17.00757,"median":-12.919935,"eighty":-10.646572,"marketCap":787501109},{"date":"2025-04-25","current":-10.073474,"twenty":-16.992523,"median":-12.900829,"eighty":-10.506428,"marketCap":896780977},{"date":"2025-05-02","current":-10.926692,"twenty":-16.945499,"median":-12.87493,"eighty":-10.47358,"marketCap":972737836},{"date":"2025-05-09","current":-10.268015,"twenty":-16.896595,"median":-12.837758,"eighty":-10.456802,"marketCap":914099729},{"date":"2025-05-16","current":-9.22086,"twenty":-16.864245,"median":-12.824716,"eighty":-10.419165,"marketCap":874414177},{"date":"2025-05-23","current":-8.677544,"twenty":-16.841798,"median":-12.774982,"eighty":-10.35027,"marketCap":822891456},{"date":"2025-05-30","current":-9.179465,"twenty":-16.826999,"median":-12.740411,"eighty":-10.284647,"marketCap":870488636},{"date":"2025-06-06","current":-11.057788,"twenty":-16.804427,"median":-12.734501,"eighty":-10.282309,"marketCap":1048610043},{"date":"2025-06-13","current":-10.172958,"twenty":-16.787499,"median":-12.717951,"eighty":-10.278305,"marketCap":964701612},{"date":"2025-06-20","current":-13.417901,"twenty":-16.781856,"median":-12.734501,"eighty":-10.282309,"marketCap":1272419584},{"date":"2025-06-27","current":-13.386798,"twenty":-16.747999,"median":-12.73478,"eighty":-10.283478,"marketCap":1269470072},{"date":"2025-07-03","current":-12.895368,"twenty":-16.702856,"median":-12.73478,"eighty":-10.288155,"marketCap":1222867778},{"date":"2025-07-11","current":-14.170598,"twenty":-16.684047,"median":-12.73506,"eighty":-10.29197,"marketCap":1343797781}],"updateTime":1752509696979}}}